CMV disease in CMV-mismatched renal transplant recipients with prophylactic low dose valaciclovir

2001 ◽  
Vol 23 (1-2) ◽  
pp. 107-111 ◽  
Author(s):  
Fredrik Sund ◽  
Jan Wahlberg ◽  
Britt-Marie Eriksson
Keyword(s):  
Renal Transplant ◽  
Low Dose ◽  
Renal Transplant Recipients ◽  
Transplant Recipients ◽  
Cmv Disease

scholarly journals Prophylaxis of Cytomegalovirus in Renal Transplant Recipients

1993 ◽  
Vol 4 (suppl c) ◽  
pp. 51-57
Author(s):  
Allan S MacDonald ◽  
David L Nicol ◽  
Philip Belitsky ◽  
Spencer Lee
Keyword(s):  
Renal Transplant ◽  
Low Dose ◽  
Risk Groups ◽  
High Titre ◽  
Renal Transplant Recipients ◽  
Transplant Recipients ◽  
Cmv Infection ◽  
Hyperimmune Globulin ◽  
Low Incidence ◽  
Cmv Disease

The incidence and outcome of cytomegalovirus (CMV) infection and disease is compared in renal transplant recipients in relation lo the use of prophylaxis wiU1 high titre anti-CMV immunoglobulin. Seventy-three CMV-negative recipients (R-) who received kidneys from CMV-posilive donors (D+) were given prophylactic CMV hyperimmune globulin inlravenously al three-week intervals lo six monilis. They also received Lhree months of oral low dose acyclovir as did the remaining 288 patients who did nol receive hyperimmune globulin. There was a low incidence of CMV disease which did not differ between groups (D+R-, 10%: D+R+, 5 .5%, D- R+, 7%: D- R-, 0.8%). The major risk factor was the use of OKT3 to treat rejection. CMV disease was seen in 22% of this group (11 of 50) . compared with only 2% (seven of 311) of those not requiring OKT3. There was only one CMV-related death. but palients with CMV disease had a reduced graft survival rate (62% versus 90%). CMV hyperimmune globulin added lo acyclovir appears to reduce the incidence of CMV disease in high risk renal recipients (D+R-) in the lower risk groups.

Erythrocyte sodium lithium countertransport in renal transplant recipients with mycophenolate mofetil and low-dose cyclosporine

2004 ◽  
Vol 36 (10) ◽  
pp. 3032-3035
Author(s):  
K. Vareesangthip ◽  
P. Hanlakorn ◽  
L. Suwannaton ◽  
R. Larpkitkachorn ◽  
D. Chuawattana ◽  
...  
Keyword(s):  
Mycophenolate Mofetil ◽  
Renal Transplant ◽  
Low Dose ◽  
Renal Transplant Recipients ◽  
Transplant Recipients ◽  
Erythrocyte Sodium

Low-dose-rate brachytherapy for prostate cancer in renal transplant recipients

Brachytherapy ◽  
2018 ◽  
Vol 17 (5) ◽  
pp. 808-815
Author(s):  
I. Rivero-Belenchón ◽  
I. Osmán-García ◽  
C.B. Congregado-Ruíz ◽  
P. Cabrera-Roldán ◽  
M.J. Jiménez-Torres ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Renal Transplant ◽  
Dose Rate ◽  
Low Dose ◽  
Renal Transplant Recipients ◽  
Transplant Recipients ◽  
Low Dose Rate ◽  
Low Dose Rate Brachytherapy

Low-dose valaciclovir prophylaxis againt cytomegalovirus disease in renal transplant recipients

2003 ◽  
Vol 16 (10) ◽  
pp. 726-729
Author(s):  
Srikanth P. Reddy ◽  
Ashok Handa ◽  
Liamchin Tan ◽  
Andrea Devaney ◽  
David Hughes ◽  
...  
Keyword(s):  
Renal Transplant ◽  
Low Dose ◽  
Renal Transplant Recipients ◽  
Transplant Recipients ◽  
Cytomegalovirus Disease

Low-dose valaciclovir prophylaxis against cytomegalovirus disease in renal transplant recipients

2003 ◽  
Vol 16 (10) ◽  
pp. 726-729 ◽  
Author(s):  
Srikanth P. Reddy ◽  
Ashok Handa ◽  
Liamchin Tan ◽  
Andrea Devaney ◽  
David Hughes ◽  
...  
Keyword(s):  
Renal Transplant ◽  
Low Dose ◽  
Renal Transplant Recipients ◽  
Transplant Recipients ◽  
Cytomegalovirus Disease
Sign in / Sign up

Export Citation Format

Share Document